Key facts
- Ferronova’s last known valuation is $14.4M (Dec 2025).
- It has raised $11.5M; the latest was Later Stage VC ($3.7M) in Dec 2025.
- Notable investors include Artesian, Allan Moss, Australian Government (Landing Pads), Booster Innovation Fund, Brisbane Angels — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Ferronova
- ·The full record, as it builds
Funding rounds
No funding rounds for Ferronova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ferronova
Developer of a magnetic nanoparticle technology designed to detect cancer. The company's technology identifies high-risk lymph nodes and metastatic spread using gamma probes with magnetic tracers, enabling hospitals to accurately diagnose, detect, and treat cancers, particularly upper gastrointestinal cancers, at an earlier stage.
- Sector
- Healthcare
- HQ
- Prospect, Australia
- Founded
- 2016
- Employees
- 10
- Website
- ferronova.com.au/
- Ownership
- Privately Held (backing)
Ferronova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ferronova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ferronova in its N-PORT filings yet. We sweep new filings monthly.